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Method Optimized design and data analysis of tag-based 
cytosine methylation assays
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Cytosine methylation Genome-wide, tag-based cytosine methylation  analysis is optimized.
Abstract
Using the type III restriction-modification enzyme EcoP15I, we isolated sequences flanking sites digested by the 
methylation-sensitive HpaII enzyme or its methylation-insensitive MspI isoschizomer for massively parallel sequencing. 
A novel data transformation allows us to normalise HpaII by MspI counts, resulting in more accurate quantification of 
methylation at >1.8 million loci in the human genome. This HELP-tagging assay is not sensitive to sequence 
polymorphism or base composition and allows exploration of both CG-rich and depleted genomic contexts.
Background
Epigenetic mechanisms of transcriptional regulation are
increasingly being studied for their potential influences in
human disease pathogenesis. Much of this interest is based
on the paradigm of neoplastic transformation, in which epi-
genetic changes appear to be universal, widespread
throughout the genome, causative of critical transcriptional
changes and predictive of disease prognosis (reviewed in
[1]). Furthermore, these epigenetic changes represent
potential pharmacological targets for reversal and ameliora-
tion of the disease process [2].
Of the large number of regulatory processes referred to as
epigenetic, there exist numerous assays to study chromatin
component distribution, cytosine methylation and
microRNA expression genome-wide. The chromatin com-
ponents include a large number of post-translational modi-
fications of histones, variant histones, DNA-binding
proteins and associated complexes, all tested by chromatin
immunoprecipitation (ChIP) approaches coupled with
microarray hybridization or massively parallel sequencing
(MPS). MicroRNAs can be identified and quantified by
using microarrays and MPS, while cytosine methylation
can be definitively studied by converting the DNA of the
genome using sodium bisulfite, shotgun sequencing the
product using MPS and mapping this back to the genome to
count how frequently cytosines remain unconverted, indi-
cating their methylation in the starting material, due to the
resistance of methylcytosine to bisulfite conversion com-
pared with unmethylated cytosines. This allows nucleotide
resolution, strand-specific, quantitative assessment of cyto-
sine methylation, with such studies performed in Arabidop-
sis [3-5] and human cells to date [6].
While this approach represents the ideal means of testing
cytosine methylation, the amount of sequencing necessary
(for the human genome, over 1 billion sequences of ~75 bp
each [6]) to generate quantitative information genome-wide
remains prohibitive in terms of cost, limiting these studies
to the few referred to above. When studying human disease,
the emphasis remains on cytosine methylation assays, as it
is generally easier to collect clinical samples for DNA puri-
fication than for ChIP or even RNA assays. However, the
cell populations harvested are rarely of high purity, and we
generally do not know the degree of change in cytosine
methylation in the disease of interest and thus the quantita-
tive discrimination required for an assay, with some studies
to date indicating that the changes may be quite subtle [7].
These concerns emphasize the need for cytosine methyla-
tion assays that can detect methylation levels intermediate
in value and changes in disease that are relatively modest in
magnitude. Certain microarray-based assays to study cyto-
sine methylation have addressed this issue, with the methy-
lated DNA immunoprecipitation (meDIP) assay amenable
to such quantification when used for CpG islands [8] and
possibly also for less CG dinucleotide-rich regions [9].
Restriction enzyme-based assays used with microarrays
have also proven to be reasonably quantitative, whether
based on methylation-sensitive (for example, the HELP
assay [10]) or methylation-dependent (for example, Meth-
ylMapper [11]) enzymes. A promising new MPS-based
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assay is reduced representation bisulfite sequencing
(RRBS), which is designed to study the CG-dense regions
defined by short MspI fragments, and provides nucleotide
resolution, quantitative data [12].
The use of MPS for what were previously microarray-
based assays has been associated with improved perfor-
mance [13], as we found when we modified our HELP
(HpaII tiny fragment Enrichment by Ligation-mediated
PCR) assay [10] for MPS, creating an assay similar to
Methyl-Seq [14]. The strength of the HELP assay involves
the comparison of the HpaII with the methylation-insensi-
tive MspI representation, allowing a normalization step that
makes the assay semi-quantitative [10]. The HELP repre-
sentation approach was improved upon by Ball et al. [15],
who developed the Methyl-Sensitive Cut Counting
(MSCC) assay, which involves digesting DNA with HpaII,
ligating an adapter to the cohesive end formed, using a
restriction enzyme site within the adapter to digest at a
flanking sequence and thus capturing the sequence immedi-
ate adjacent to the HpaII site. By adding a second MPS-
compatible adapter, a library can be generated for MPS,
allowing the counting of reads at these sites to represent the
degree of methylation at the site. The authors demonstrated
the assay to be reasonably quantitative, testing over 1.3 mil-
lion sites in the human genome, representing not only HpaII
sites clustered in CG-dense regions of the genome (approx-
imately 12% of all HpaII sites are located in annotated CpG
islands in the human genome [16]) but also the remaining
majority of the genome in which CG dinucleotides are
depleted, a genomic compartment not tested by RRBS as
currently designed. A focus on the CG-dense minority of
the genome will fail to observe changes such as those at
CG-depleted promoters (such as OCT4  [17]) and CpG
island shores [18], and within gene bodies where cytosine
methylation has been found to be positively correlated with
gene transcription [15]. It is likely, therefore, that an assay
system that can study both CG-dense and CG-depleted
regions will acquire substantially more information about
epigenomic states than those directed at the CG-dense com-
partment alone.
In the current study, we tested whether the use of an MspI
control would improve MSCC assay performance, as we
had found for microarray-based HELP, and whether we
could develop an analytical pipeline for routine use of this
assay in epigenome-wide association studies. We also
explored the use of longer tags than those employed in the
MSCC, and added T7 RNA polymerase and reverse tran-
scription steps to allow the generation of libraries without
contaminating products, thus obviating the need for gel
extraction. The influence of base composition and fragment
length parameters as potential sources of bias were also
tested, using the H1 (WA01) human embryonic stem (ES)
cell line. The outcome is a modified assay that combines
the strengths of MSCC and HELP-seq/Methyl-seq, and the
supporting analytical workflow that maximizes the quanti-
tative capabilities of the data generated.
Results and discussion
Library preparation and sequencing
We generated HELP tagging libraries with HpaII- or MspI-
digested DNA derived from human ES cells using the
experimental approach shown in Figure 1. The assay differs
from MSCC [15] by using EcoP15I instead of MmeI, gen-
erating longer flanking sequences (27 as opposed to 18 to
19 bp) and the addition of a T7 polymerase and reverse
transcription step to allow the generation of the library
without contaminating single-adapter products, while in
addition obviating the need for gel extraction. After the
library preparation, a single band of 125 bp in length was
generated, as expected. Libraries were sequenced using an
Illumina Genome Analyzer (36 bp single end reads) and the
sequences were analyzed and aligned using Illumina pipe-
line software version 1.3 or 1.4. A summary of the Illumina
Figure 1 HELP-tagging assay design and library preparation. The 
genomic DNA is digested by HpaII or MspI, the former only cutting at 
CCGG sequences where the central CG dinucleotide is unmethylated. 
The first Illumina adapter (AE) is ligated to the compatible cohesive 
end created, juxtaposing an EcoP15I site beside the HpaII/MspI diges-
tion site and allowing EcoP15I to digest within the flanking DNA se-
quence as shown. An A overhang is created, allowing the ligation of 
the second Illumina adapter (AS, green). This will create not only AE-in-
sert-AS products but also AS-insert-AS molecules. By performing a T7 
polymerase-mediated in vitro transcription from a promoter sequence 
located on the AE adapter, we can selectively enrich for the AE-insert-
AS product, following which limited PCR amplification is performed to 
generate a single sized product for Illumina sequencing. RT, reverse 
transcription.
T7
A
A
A A
RNA
cDNA
T7
T7
T
7
T
7
T
7
C
G
G CGG
CCGG CGG
me
MspI/HpaII digestion
First adapter ligation
EcoP15I digestion
Second adapter ligation
In vitro transcription
RT reaction
T
T
PCR amplification
Massively parallel sequencing with Illumina GA
A
A
T
AT
A
CGG C C
C
G
G
C
G
G
C
C
C
CSuzuki et al. Genome Biology 2010, 11:R36
http://genomebiology.com/2010/11/4/R36
Page 3 of 11
Figure 2 Data transformation and bisulfite validation. (a) Scatter plot showing the relationship between the number of HpaII and MspI reads at 
each locus. (b) The location of the data point on the scatter plot indicates whether it is likely to be less or more methylated with larger or smaller angles 
B subtended as shown, while the confidence of the measurement will be greater when more reads represent the data point, represented by the 
length of line c. (c) The HpaII count correlates negatively with the degree of methylation, with more counts occurring at loci with less methylation. 
(d) Transformation of the data to the B angle measure to normalize HpaII by MspI counts substantially improves the correlation with bisulfite MassAr-
ray validation data.
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analysis results for each replicate is shown in Table S1 in
Additional file 1.
Data quality and reproducibility
Based on our experimental design, successfully generated
products would be expected to possess a 5'-CGCTGCTG
sequence at the 3' end of the read, the first two nucleotides
(CG) representing the cohesive end for ligation of HpaII/
MspI digestion products, the remaining six nucleotides the
EcoP15I restriction enzyme recognition site. In order to
evaluate the yield of desired products, we counted the num-
ber of reads containing this sequence and plotted the start-
ing positions of this sequence within the reads obtained. We
observed that approximately two-thirds of the reads con-
tained the expected sequence, and found that the majority
was located at base positions 25 and 26, consistent with the
known digestion properties of the restriction enzyme [19].
Removal of the approximately 30% of reads lacking the
CG-EcoP15I sequence was performed to eliminate spurious
sequences. In order to investigate sequence quality further,
we also determined the number and relative position of Ns
(ambiguous base calls) within the reads obtained. Overall,
few reads were found to contain Ns, and where they were
present, they were found to be evenly distributed by posi-
tion within the sequence. To test data reproducibility, we
compared the results of three experimental replicates
against each other using the Pearson correlation coefficient
metric. The results of this study showed that all replicates
were highly correlated (all the r values exceed 0.9), which
confirmed that the technical reproducibility of this assay
was excellent (Table S2 in Additional file 1).
Distribution of MspI/HpaII sequence tags
We merged three lanes of MspI data and observed that
approximately 80% of the 2,292,198 annotated HpaII sites
in the human genome (hg18) were represented by at least
one read, for a total of over 1.8 million loci throughout the
genome. The mean numbers of reads per locus for MspI
and HpaII were 3.94 and 1.82, respectively, and MspI
counts were distributed evenly across all genomic compart-
ments examined (Table S3 in Additional file 1). We hypoth-
esize that a combination of incomplete genomic coverage
and polymorphisms within some CCGG sites (as we have
previously observed [10]) accounts for the 20% of HpaII
sites that were not represented by any reads.
Normalization of HpaII by MspI counts and data 
transformation
When we plot the MspI count on the x-axis and HpaII count
on the y-axis for each HpaII site, we can see two major
groups of values in the plot (Figure 2a), separated into loci
with high or with minimal HpaII counts. This plot helped us
to develop a new method for normalizing HpaII counts in
terms of variability of the MspI representation. We recog-
nize that hypomethylated loci are associated with relatively
greater HpaII counts and a larger angle B (Figure 2b, left)
whereas methylated loci will be defined by smaller angle
values (Figure 2b, middle). Furthermore, some loci will
tend to be sequenced more readily than others, and may
have identical B values but differing distances from the ori-
gin (c distance), allowing a confidence score for identical
methylation values (B) in terms of the c distance values
(Figure 2b, right). To test this model, we used bisulfite Mas-
sArray to test quantitatively the cytosine methylation values
for 61 HpaII sites (Tables S4, S5 and S6 in Additional file
1), choosing loci representing all components of the B
angle spectrum of values. In Figure 2c, d we show the cor-
relations between these gold standard cytosine methylation
values and raw HpaII counts or B angle values. We find that
there is the same negative correlation (R2 = 0.502) between
HpaII counts and cytosine methylation values as demon-
strated in the MSCC technique [15], and that the angular
transformation of the data incorporating the MspI normal-
ization substantially improves this correlation (R2 = 0.826),
defining the optimal approach for processing of these data.
We represent the data for University of California Santa
Cruz (UCSC) genome browser visualization as wiggle
tracks, with higher B angle values defining less methylated
loci. Methylated loci with zero values that would be other-
wise difficult to visualize as having been tested are repre-
sented as small negative values. We show the details of the
analytical workflow in Figure 3 and an example of a UCSC
genome browser representation of HELP-tagging data in
Figure S1 in Additional file 1. All data are available
through the Gene Expression Omnibus database (accession
number [GEO:GSE19937]) and as UCSC genome browser
tracks [20].
Potential sources of bias: base composition and fragment 
length
As the number of reads at CCGG sites following MspI
digestion should not be influenced by methylation, the rep-
resentation obtained from MspI digestion allowed us to
look for systematic sources of bias inherent to the assay. A
major concern was that base composition could be a source
of such bias, as it has been reported that Illumina sequenc-
ing can be influenced by GC composition [21], possibly
because of the gel extraction step [22]. Our protocol does
not require gel extraction and only begins to show an under-
representation of sequences when the (G+C) content
exceeds approximately 80% (Figure 4a). We also tested to
see whether the sizes of the MspI fragments generated
influenced the counts obtained, as the digestion by type III
endonucleases like EcoP15I is most efficient when a pair of
enzymes is present in convergent orientation on the same
DNA molecule [19]. We find that there is indeed an over-
representation for shorter (≤300 bp) and a corresponding
modest under-representation for larger MspI fragments
(Figure 4b).Suzuki et al. Genome Biology 2010, 11:R36
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Figure 3 HELP-tagging analysis workflow. The analysis workflow for HELP-tagging data is illustrated. Only sequence reads that contain the adapter 
sequence and map to a single or ≤ 10 sites are retained, the latter repetitive sequences distributed by weighting among the matched loci. Potential 
polymorphic loci are annotated. Normalization of HpaII by MspI using the angle calculation described in the previous figure is performed and files are 
generated for genome browser visualization. UCSC, University of California Santa Cruz.
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Identification of polymorphic CCGG sequences
Whereas MSCC used MmeI and generates an 18- to 19-bp
sequence flanking the HpaII site [15], our use of EcoP15I
generates a 27-bp flanking sequence. We asked whether this
size difference influenced our ability to align sequences to
the reference genome. We truncated our sequence reads to
19 bp to mimic the MSCC read length and found that this
caused a profound loss of ability to align reads unambigu-
ously (Table S7 in Additional file 1). To compensate for the
low alignment rate, the MSCC report described an inge-
nious strategy of alignment to the sequences immediately
flanking the annotated HpaII sites in the reference genome
[15], an approach sufficiently powerful that it generated the
well-validated data that they described. However, it does
not offer the possibility of identifying polymorphic HpaII
sites at the high frequencies that we previously observed for
our HELP-seq assay [10]. We tested whether our longer
sequences allowed the identification of loci at which an
HpaII site is annotated in the reference genome but we
obtain no sequence reads, and the opposite situation where
we observed at least four MspI reads (the average number
per annotated MspI/HpaII site) flanking a locus not anno-
tated in the reference genome. In Table S8 in Additional file
1 we list approximately 6,600 candidate polymorphic HpaII
sites, of which examples are shown in Figure 5, confirmed
by targeted resequencing of those loci. The 6,600 loci were
selected based on overlap with dbSNP entries, allowing us
to evaluate the pattern of sequence variability at these loci.
Approximately 80% of the SNPs are C:G to T:A transver-
sions, consistent with deamination-mediated decay of
methylcytosine being the cause of the polymorphism [23].
Polymorphic CG dinucleotides are major potential sources
of error not only for microarrays, which are designed to a
consensus genomic sequence, but also for both bisulfite
sequencing, which would read the C to T transversion as
unmethylated, and mass spectrometry-based assays, requir-
ing the development of specific analytical approaches such
as we have described [24].
DNA methylation studies of human embryonic stem cells
To test whether the HELP-tagging assay was generating
data that are biologically plausible, we tested the methyla-
tion of different genomic sequence compartments as den-
sity plots of B angle values for the human ES cells used in
these studies. In Figure S2a in Additional file 1 we show
how promoters (defined as -2 kb to 2 kb from the transcrip-
tion start site of RefSeq genes), gene bodies (the remaining
region within the RefSeq gene) and intergenic (all other)
sequences compare, finding the expected enrichment of
hypomethylated loci with larger B angle values in promoter
regions. When we compared unique with repetitive
sequences, again we found the expected pattern of
increased methylation of repetitive DNA compared with
unique sequences (Figure S2b in Additional file 1). Com-
bining these observations, we tested whether the transpos-
able element component of annotated repetitive DNA
sequences showed any tendency to unusual methylation
near gene promoters. In Figure 6 we show that while trans-
posable elements are generally methylated and are depleted
near gene promoters, those that are proximal to promoters
Figure 4 Base composition and fragment length influences on se-
quence counts. (a) The proportion of (G+C) nucleotides was calculat-
ed for the 50-bp sequence centered around each annotated CCGG in 
the reference human genome. The base composition of all of the MspI 
sequences generated from the human ES cell line studied was also cal-
culated. The relative proportion for (G+C) content in 2% bins for each 
set of data was calculated and plotted as shown. The black line shows 
the proportions in the reference genome, while the red line illustrates 
the distribution we observed in our MspI experiment. Two peaks rep-
resenting base composition in repetitive sequences are apparent. The 
MspI distribution closely matches the expected distribution except 
when the base composition exceeds approximately 80%, when it is 
slightly under-represented. (b) We calculated the relative frequencies 
of MspI digestion product sizes in the human reference genome. In 
this case we found that the shorter fragments are more likely to be se-
quenced than larger (≥300 bp) fragments. The three major peaks ob-
served represent Alu short interspersed repetitive element (SINE) 
sequences.
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tend to be less methylated than those located more distally.
While many types of transposable elements were repre-
sented in this promoter-proximal hypomethylated group,
we found a subset to be the most markedly over-repre-
sented, as shown in Figure 6c.
The outcome of these studies was an improvement in the
previously described MSCC [15] and HELP-seq [10]
assays, not only by means of technical modifications such
as the use of EcoP15I but also because of the concurrent use
of MspI for normalization. The effect of these modifica-
tions was not only to increase the accuracy of the assay but
Figure 5 Polymorphic HpaII sites identified by HELP-tagging. Examples of HpaII sites (a) annotated in the reference genome sequence but not 
represented by MspI reads or (b) not annotated in the reference human genome and represented by at least four MspI reads are shown. In each case 
there is a SNP defined by dbSNP that indicates the C:T to G:A transversion that eliminates or restores the CCGG HpaII site.
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also to enhance the ability to align sequences to the genome
and thus identify polymorphic HpaII/MspI sites. The means
of normalization of HpaII by MspI using an angular metric
is an innovation that improved the data accuracy substan-
tially and may have applications in other MPS assay nor-
malization strategies. We were also able to discard reads
that did not contain the expected adapter sequences, and
created a straightforward data analytical pipeline that will
facilitate processing of these HELP-tagging data by others.
The potential sources of systematic artifacts due to base
composition or digestion product size were evaluated.
Apart from a modest decrease in representation in regions
above approximately 80% (G+C) content, base composi-
tion did not cause biases in representations, possibly in part
due to our avoidance of a gel purification step in library
preparation [22]. Fragment length does influence the out-
come, most likely due to effects on EcoP15I digestion [19],
although the effects should be similar for both HpaII and
MspI and should, therefore, largely cancel each other out in
the normalization step. It is possible that endogeneous
EcoP15I sites could influence the representations, but to
have an effect they would have to be located within the 27
bp adjacent to HpaII/MspI sites and would cause digestion
of the ligated adapter, causing those loci to be under-repre-
sented in both HpaII and MspI datasets. The most likely
effect of these endogeneous sites is that they contribute to
the proportion of loci at which we could not obtain
sequence reads.
Our exploration of the distribution of cytosine methyla-
tion in the same human ES cell line studied by Lister et al.
[6] showed consistent results, with hypomethylation of
transcription start sites and methylation of transposable ele-
ments, as expected from long-standing observations in the
field. We furthermore discovered a limited subset of trans-
posable elements that is hypomethylated when in close
proximity to transcription start sites. When this subset was
studied to determine whether certain types of transposable
elements were disproportionately over-represented, we
found two broad classes, one of transposable element fos-
sils with no innate capacity to replicate themselves (the
ancient DNA, long interspersed repetitive elements
(LINEs) and short interspersed repetitive elements (SINEs)
shown in Figure 6c) and younger ERV1 long terminal
repeat retroelements. Loss of methylation of functionally
inactive transposable elements is likely to be of no negative
consequence to the host genome, consistent with the host
defense hypothesis [25], while the young ERV long termi-
nal repeats represent a group of transposons whose function
has been harnessed as promoters of endogeneous genes
[26,27]. This observation demonstrates the value of a high-
resolution, genome-wide assay like HELP-tagging to define
potential functional elements in an unbiased manner.
Conclusions
We propose that MPS-based assays such as RRBS [12],
MSCC [15] and HELP-tagging will prove to be the assays
of choice for epigenome-wide association studies in human
disease, with the latter two preferable as we begin to
explore the CG-depleted majority of the genome. It should
not be necessary to run MspI assays every time a HELP-
tagging assay is performed, suggesting that a common
MspI dataset can serve as a universal reference for a spe-
cies, allowing a single lane of Illumina sequencing of the
HpaII library to provide the methylation data for that sam-
ple. The development of analytical pipelines to support
analysis of these datasets will be critical to the success of
these projects, while the careful ongoing assessment of
potential sources of bias will also be essential for improving
assay performance.
Figure 6 Identification of a position effect on DNA methylation in transposable elements located close to gene promoters. The distance 
from RefSeq gene transcription start sites and DNA methylation status are shown. The x-axis displays the distance from transcription start sites (TSSs). 
HpaII sites were categorized into three groups by angle, 0 to 30 (green), 31 to 60 (red) and 61 to 90 (blue)). (a) Number of HpaII sites; (b) proportions 
of each angle category (%); (c) types of transposable element disproportionately highly represented in the promoter-proximal hypomethylated trans-
posable element group.
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Materials and methods
Cell preparation and DNA purification
H1 human ES cells (NIH code WA01 from Wicell Research
Institute, Madison, WI, USA) were cultured on matrigel
(BD Biosciences, San Diego, CA, USA), at 37°C, 5% O2
and 5% CO2. Amplified human ES cell pluripotency was
assessed by flow cytometry with SSEA4, CD24 and Oct4
markers. To extract DNA, the cells were suspended in 10
ml of a solution of 10 mM Tris-HCl (pH 8.0), 0.1 M EDTA
and 1 ml of 10% SDS to which 10 μl of RNase A (20 mg/
ml) was added. After incubation for 1 hour at 37°C, 50 μl of
proteinase K (20 mg/ml) was added and the solution was
gently mixed and incubated in a 50°C water bath overnight.
To purify the lysate, it was extracted three times using satu-
rated phenol, then twice with chloroform, and dialyzed for
16 hours at 4°C against three changes of 0.2× SSC. Follow-
ing dialysis, the DNA was concentrated by coating the dial-
ysis bags in polyethylene glycol (molecular weight 20,000).
The purity and final concentration of the purified DNA was
checked by spectrometry (Nanodrop, Wilmington, DE,
USA).
Illumina library preparation
The sample preparation steps are illustrated in Figure 1.
Two custom adapters were created for HELP-tagging,
referred to as AE and AS. As well as an Illumina adapter
sequence, adapter AE contains an EcoP15I recognition site
and a T7 promoter sequence. Adapter AS contains an Illu-
mina sequencing primer sequence. The adapter and primer
sequences for library preparation are listed in Table S9 in
Additional file 1. Genomic DNA (5 μg) was digested with
HpaII and MspI in separate 200 μl reactions and purified by
phenol/chloroform extraction followed by ethanol precipi-
tation. The digested genomic DNA was ligated to adapter
AE using a New England Biolabs Quick Ligation Kit (25 μl
of 2× Quick ligase buffer, 3 μg of HpaII-digested DNA or 1
μg of MspI-digested DNA, 0.1 μl of Adapter AE (1 μM), 3
μl of Quick Ligase in a final volume of 50 μl). After AE
ligation, the products were purified using Agencourt
AMpure beads (Beckman Coulter, Brea CA, USA), then
digested with EcoP15I (New England Biolabs). The restric-
tion fragments were end-repaired to inhibit to dimerization
of adapters, and tailed with a single dA, at the 3' end. After
the dA tailing reaction, adapter AS was ligated to the dA-
tailed fragments using a New England Biolabs Quick Liga-
tion Kit (25 μl of 2× Quick ligase buffer, 2.5 μl of adapter
AS (10 μM), 2.5 μl of Quick Ligase in a final volume 50
μl). After ligation, products were purified using the Min-
Elute PCR purification kit (Qiagen, Hilden, Germany) and
in vitro-transcribed using the Ambion MEGAshortscriptkit
(Life Technologies, Carlsbad, CA, USA). Following in
vitro transcription, products were purified with an RNeasy
clean-up kit (Qiagen) before reverse transcription was per-
formed using the Invitrogen SuperScript III kit (Life Tech-
nologies). The first strand cDNA produced was used as a
template for PCR using the following conditions: 96°C for
2 minutes, then 18 cycles of 96°C for 15 seconds and 72°C
for 15 seconds followed by 5 minutes at 72°C for the final
extension. After PCR, the library was purified using a
QIAQuick PCR clean-up kit (Qiagen).
Single-locus quantitative validation assays
Bisulfite conversion and MassArray (Sequenom, San
Diego, CA, USA) were performed using an aliquot of the
same sample of DNA as was used for the high-throughput
assays described above. Bisulfite conversion was per-
formed with an EZ DNA Methylation kit (Zymo Research,
Orange, CA, USA). Bisulfite primers were designed using
MethPrimer [28], specifying the desired product length
(250 to 450 bp), primer length (23 to 29 bp) and primer Tm
(56 to 62°C). PCR was performed using FastStart High
Fidelity Taq polymerase (Roche, Basel, Switzerland) with
the following conditions: 95°C for 10 minutes, then 42
cycles of 95°C for 30 seconds, primer-specific Tm for 30
seconds and 72°C for 1 minute, followed by 72°C for 10
minutes for the final extension. Primer-specific Tm and
sequence information are provided in Table S6 in Addi-
tional file 1. Bisulfite MassArray assays were performed by
the institutional Genomics Core Facility. The data were
analyzed using the analytical pipeline we have previously
described [24].
Bioinformatic analysis
Four lanes of sequencing were performed using an Illumina
GA IIx Sequencer at the institutional Epigenomics Shared
Facility. Three lanes were used for technical replicates of
MspI, for the methylation-insensitive reference dataset.
Images generated by the Illumina sequencer were analyzed
by Illumina pipeline software (versions 1.3 to 1.4). Initial
data processing was performed using the default read length
of 36 bp, after which we isolated the sequences in which we
found adapter sequences on the 3'-end, replaced the adapter
sequence with a poly(N) sequence of the same length, and
re-ran the Illumina ELAND pipeline again on these
sequences with the sequence length set at 27 bp (the 2 to 28
bp subsequence). The data within the ELAND_extended.txt
files were used for counting the number of aligned
sequences adjacent to each CCGG (HpaII/MspI) site anno-
tated in the hg18 freeze of the human genome at the UCSC
genome browser. We permitted up to two mismatches in
each sequence, and allowed a sequence to align to up to a
maximum of 10 locations within the genome. For non-
unique alignments, a sequence was assigned a partial count
for each alignment location amounting to 1/n, where n rep-
resents the total number of aligned positions. To normalize
the data between experiments, the number of sequences
associated with each HpaII site was divided by the total
number of sequences (including partial counts) aligning toSuzuki et al. Genome Biology 2010, 11:R36
http://genomebiology.com/2010/11/4/R36
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all HpaII sites in the same sample. We refer to this figure as
the fixed count below.
To examine an influence of (G+C) mononucleotide con-
tent on counts of sequences obtained, we extracted the
(G+C) annotation from the hg18 freeze of the human
genome at UCSC and examined the distribution of
sequence counts according to (G+C) content. Annotated
percentages of (G+C) content were available for adjacent 5-
bp windows. For each annotated HpaII site, we calculated
the mean percentage (G+C) for a 50-bp region centered at
the restriction site. Counts of sequences associated with
HpaII sites were obtained for 50 sequential non-overlap-
ping windows of 2% (G+C) (the minimum possible in a
sample of 50-bp regions). These data were then normalized
as a proportion of the total number of fragments. Compari-
sons were made to the expected frequencies, which for each
2% (G+C) bin was represented by the counts of HpaII sites
falling within a range relative to the total number of HpaII
sites in the genome. This analysis was performed on both
HpaII and MspI-digested DNA for comparison.
The potential effect of distance between HpaII sites on
sequences counts obtained at each HpaII site was measured
by summing the counts of sequences aligning within each
restriction fragment, and normalizing the result with respect
to total sequence count. As with the (G+C) analysis above,
this was performed for both MspI and HpaII digested
restriction fragments. The data were compared with the
expected distribution determined by performing virtual
restriction digestion using genomic HpaII site coordinates,
and normalizing the number of virtual fragments of each
size with respect to the total number of these virtual frag-
ments.
Additional material
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